July 1, 2024

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

NRG 2024 Summer Meeting Registration is Open!

Join us for the NRG Oncology Summer Meeting July 25th - July 27th at the Sheraton Denver Downtown Hotel in Denver, CO. The Meeting will be held in-person only (with limited virtual session offerings). REGISTER TODAY! Registration after July 2^nd will incur a late fee.

Summer 2024 Symposium “Novel, Next and Now: Checkpoint Inhibitors and Cellular Immunotherapy Progress in Oncology”

Join us in-person or virtually! Thursday, July 25, 2024, 8am to 12pm MDT.

Speakers will focus their presentations on the current state of immunotherapy focusing in gynecologic malignancies, future immunotherapy options beyond checkpoint inhibitors with lessons learned from non-gynecologic malignancies, and how to establish successful phase I and cellular therapy teams in both academic and community settings.

NRG Oncology Protocol Support Committee (PSC) – Educational Sessions

Please be sure to sign up to attend the PSC Sessions being held during the NRG Oncology Summer Meeting in Denver. The PSC will host a Continuing Education session and Roundtable presentations on Thursday, July 25; and a Protocol Spotlight Session (NRG-CC011, NRG-GI008, NRG-BR008) on Friday, July 26. Please refer to the posted session flyers and agendas (login required) for more details about the PSC programing offered at #NRG2024. The PSC programming at #NRG2024 has been approved by the Virginia Nurses Association to award contact hours. The Virginia Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

#NRG2024 Social Media Workshop – Virtual Session

The NRG Oncology Communications Committee is pleased to announce our Social Media Workshop as part of #NRG2024. The workshop, being held as a virtual session, is scheduled for Monday, July 22, 2024, 10-11am EDT. Drs. Kristin Higgins and Miriam Knoll, members of the NRG Oncology Communications Committee, are the workshop chairs. The session speakers include Dr. Amy Comander from Massachusetts General Hospital; she will be discussing advocacy and lifestyle medicine; Dr. Stephen Chun from MD Anderson and Dr. Lauren Henke from University Hospitals/Case Western University will be presenting about NRG’s new Podcast Project. Please see the session flyer for details. Register here for the session.

Session Flyers

Promotional flyers for the following #NRG2024 Meeting sessions are now available on the NRG website:

• Early Career & New Investigator Educational Session
• FORTE Workshop
• General Session
• Head & Neck Cancer Symposium
• NRG NCORP Town Hall
• Translational Science Symposium



Social Media Ambassadors wanted for #NRG2024

Apply to be a Social Media Ambassador for the #NRG2024 Summer Meeting in Denver. If interested, please send an e-mail (& please include your social account handle/s) to: communications@nrgoncology.org.

TERMINATIONS

GYNECOLOGIC

• GOG-0188: Terminated effective August 30, 2023; version date: December 15, 2014 (posted on NRG Oncology)
• GOG-0238: Terminated effective April 25, 2024; version date: May 28, 2019 (posted on CTSU)
• GOG-0279: Terminated effective June 1, 2024; version date: July 21, 2016 (posted on NRG Oncology)
• NRG-GY007: Terminated effective May 22, 2024; version date: February 28, 2020 (posted on NRG Oncology)
• NRG-GY016: Terminated effective March 27, 2024; version date: June 11, 2020 (posted on CTSU)

AMENDMENTS

GENITOURINARY

NRG-GU008: Amendment 5, version date June 03, 2024 (posted on CTSU)

GYNECOLOGIC

NRG-CC010: Amendment 1; version date: April 5, 2024. Open to Canadian sites effective July 1, 2024 (posted on CTSU). 

HEAD & NECK

NRG-HN011: Amendment 1, version date May 13, 2024 (posted on CTSU)

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANKS

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

Shipping samples in extreme weather conditions

The NRG Oncology Biospecimen Bank staff would like to remind you to keep in mind weather conditions when shipping samples. 

• Be sure to add sufficient dry ice to frozen shipments. In extreme temperatures, if possible, store the samples in -80° C until the temperature comes down.
• Frozen biospecimens should be shipped to the bank on Monday through Wednesday for Tuesday through Thursday delivery.
• Do not ship any biospecimens the day before a holiday. Watch the NRG Weekly Broadcasts for holiday closure notices and instructions.
• Be aware of the weather conditions in your area and where the biospecimens will be shipped.
• In temperatures over 80° F, use a cool pack when shipping FFPE blocks.
• Always refer to the protocol or manual (Biospecimen Collection and Submission Manual or Pathology and Correlatives Manual) for shipping instruction.  

3. CANCER PREVENTION & CONTROL

NRG-CC010: The study is open to NRG sites in Japan and South Korea. The optional biospecimen collection does not apply to sites participating in these countries.

4. GASTROINTESTINAL

NRG-GI008/CIRCULATE-North America: Webinar with Natera. Please see the memorandum, dated July 1, 2024, (posted on CTSU) for details and how to register for the session on July 17. Please note: Google Chrome is the preferred browser to register for the webinar.

5. GENITOURINARY

NRG-GU008: Overdue follow up prostate forms will need lab data entered in the follow up folders.  Due to an error in rave the forms were not populating properly. This was corrected causing the missing data forms to roll out. They will appear overdue.

6. GYNECOLOGIC

NRG-GY028: ETCTN has approved the submission of unstained slides when a block absolutely cannot be submitted. This will be included in the next protocol amendment. Until such time, details regarding this alternate submission can be found here.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

7. HEAD & NECK

NRG-HN008 - Reminder: please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important. 

8. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, NRG-BR009, NRG-CC011, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, August 7, 2024. The VisionTree staff will also be at the NRG 2024 summer meeting. Please look for them at the Round Table session on Thursday, July 25.

Drug Safety updates have been issued for the following studies:

1. Reminder: Independence Day Holiday Closures

The NRG Oncology Operations offices, Statistics and Data Management Centers (SDMCs), Biospecimen Banks, and McKesson's Clinical Research Services will be closed on Thursday, July 4, 2024 in observance of the Independence Day holiday. In addition, the Philadelphia West Operations office and the Philadelphia SDMC office will be closed on Friday, July 5. Update: the Philadelphia East Operations office will close at 1pm EDT on Wednesday, July 3 and will also be closed on Friday, July 5. Please refer to the memo posted on CTSU for more information about these closures and shipping information for the banks.

2. Membership Reminders: Please take a moment to review and update your site person rosters!

NRG Oncology Members are required to designate individuals to fill the NRG Oncology Primary Roles. Primary Roles are:

• Check Addressee
• Contact PI
• LAPS PI
• Lead RA
• Co-Lead RA (optional)
• Local Lead RA
• Principal Investigator (A maximum of 3 and the contact PI is counted as 1)

These roles are used to communicate with respect to NRG Oncology studies and other important information. In order for a person to be assigned a Primary Role, he/she must have an active CTEP ID and be listed on the site's NRG Oncology Roster for the specific institution. A completed NRG Primary Role Change Form (located on NRG Oncology website, under Membership) must be submitted to roster@nrgoncology.org for any Primary Role changes.

The Roster Update Management System (RUMS) allows authorized people at clinical sites to manage roster data for secondary roles using a web-based application. Authorized persons can use RUMS to manage person secondary roles, to request the addition or withdrawal of persons to their associated clinical sites, and to request the addition or withdrawal of child sites from their local network. NCORP authorized users should request rostering of NCORP sites, investigators, and research associates via NCORP-SYS. A person must be rostered before any roles may be requested in RUMS. 

Required secondary roles are Local PI, Contract Contact, Fiscal Contact

Please take a moment and review your roster using RUMS or NCORP-SYS as applicable to ensure all of your network personnel are up to date. Contact roster@nrgoncology.org for assistance.

3. NRG NCORP Neurocognitive Workshop– Register for the webinar to be held on Monday, July 15, 2024, 4:00 – 5:30pmET

Presenters will discuss new and ongoing NRG trials to mitigate neurocognitive changes, explore implementation science in areas where NRG trials have changed clinical care guidelines and discuss ways to build upon previous NRG trials related to neurocognitive preservation during or after cancer. The flyer with agenda can be found here.

Register in advance for this workshop: https://bit.ly/NCORPWorkshop. After registering you will receive an email with the link to join the webinar.

4. NRG Mentorship Working Group Update

Are you a new CRA or CTN within NRG Oncology? Would you like a mentor to help guide you through your new role as a CRA or CTN? Are you an institution in need of more guidance after an audit? The Mentorship Working Group can provide you with a mentor! You can apply for a mentor by going to the Introductory Materials page on the NRG website. You will find the Mentor Form to complete. The instructions on how to submit are located on the form. Hope to hear from you soon!

NRG Oncology is pleased to report the scientific articles that appeared during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

PUBLISHED ARTICLES

Chun SG, Hu C, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Kavadi VS, Narayan S, Iyengar P, Robinson C, Rothman J, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD. Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2024 Jun 27. doi: 10.1001/jamaoncol.2024.1841. Epub ahead of print. PMID: 38935373. Read more.

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS

American Brachytherapy Society (ABS) World Congress; Jul 10-13, 2024; National Harbor, MD

Canadian Association of Radiation Oncology (CARO); Sep 11-14, 2024; Vancouver, BC

European Society for Medical Oncology (ESMO); Sep 13-17, 2024; Barcelona, Spain

International Society for Quality-of-Life Research (ISOQOL); Oct 13-16, 2024; Cologne, Germany

PA Breast Cancer Coalition (PBCC); Oct 15, 2024; Harrisburg, PA

Radiological Society of North America (RSNA); Dec 1-5, 2024; Chicago, IL

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Society of Clinical Oncology (ASCO); May 30-Jun 3, 2025; Chicago, IL; due to publications committee Jan 14, 2025; submission deadline Jan 28, 2025; LBA Mar 5, 2025 (placeholder required)

American Society of Clinical Oncology (ASCO) GI; Jan 23-25, 2025; San Francisco, CA; due to publications committee Sep 10, 2024; submission deadline Sep 24, 2024; LBA Oct 24, 2024 (placeholder required)

American Society of Clinical Oncology (ASCO) GU; Feb 13-15, 2025; San Francisco, CA; due to publications committee Oct 11, 2024; submission deadline Oct 15, 2024; LBA Nov 14, 2024 (placeholder required)

American Society for Radiation Oncology (ASTRO); Sep 29-Oct 2, 2024; Washington, DC; LBA Jul 12, 2024

EORTC-NCI-AACR Symposium on Molecular Targets and therapies; Oct 23-25, 2024; Barcelona, Spain; LBA Sep 26, 2024

European Society of Gynaecological Oncology (ESGO); Feb 20-23, 2025; Rome, Italy; due to publications committee Oct 14, 2024; submission deadline Oct 28, 2024; LBA Jan 15, 2025 (placeholder required)

International Gynecologic Cancer Society (IGCS); Oct 16-18, 2024; Dublin, Ireland; LBA Jul 2, 2024, 23:59 IST

San Antonio Breast Cancer Society (SABCS); Dec 10-14, 2024; San Antonio, TX; submission deadline Jul 10, 2024, 11:59 pm CT; LBA Sep 30, 2024, 11:59 pm CT

Society for Immunotherapy of Cancer (SITC); Nov 6-10, 2024; Houston, TX; LBA Sep 12, 2024

Society for Neuro-Oncology (SNO); Nov 21-24, 2024; Houston, TX; LBA Sep 3, 2024, 5:00 pm ET (placeholder required)

Society of Surgical Oncology (SSO) Annual Meeting; Feb 14-17, 2025; Scottsdale, AZ; due to publications committee Sep 16, 2024; submission deadline Sep 30, 2024

SSO – Advanced Cancer Therapies; Mar 27-29, 2025; Tampa, FL; due to publications committee Sep 2, 2024; submission deadline Sep 16, 2024